ArticleMolecular carcinogenesis2019

Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF

Evan L Carpenter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.